Related Experiment Video
Updated: Dec 30, 2025

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
Published on: March 28, 2018
A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End
Seung Wook Yang1, Lei Li2, Jon P Connelly1
1Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
Alternative polyadenylation (APA) contributes to transcriptome complexity by generating mRNA isoforms with varying 3' UTR lengths. APA leading to 3' UTR shortening (3' US) is a common feature of most cancer cells; however, the molecular mechanisms are not understood. Here, we describe a widespread mechanism promoting 3' US in cancer through ubiquitination of the mRNA 3' end processing complex protein, PCF11, by the cancer-specific MAGE-A11-HUWE1 ubiquitin ligase. MAGE-A11 is normally expressed only in the male germline but is frequently re-activated in cancers. MAGE-A11 is necessary for cancer cell viability and is sufficient to drive tumorigenesis. Screening for targets of MAGE-A11 revealed that it ubiquitinates PCF11, resulting in loss of CFIm25 from the mRNA 3' end processing complex. This leads to APA of many transcripts affecting core oncogenic and tumor suppressors, including cyclin D2 and PTEN. These findings provide insights into the molecular mechanisms driving APA in cancer and suggest therapeutic strategies.
Insights
Cancer cells shorten mRNA 3' untranslated regions (UTRs) via a mechanism involving the cancer-specific protein MAGE-A11. This protein targets PCF11 for ubiquitination, impacting gene expression and promoting tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Alternative polyadenylation (APA) generates diverse mRNA isoforms with different 3' UTR lengths.
- Shortened 3' UTRs (3' US) are prevalent in cancer, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms driving 3' US in cancer.
- To identify the role of cancer-specific proteins in APA regulation.
Main Methods:
- Investigated the ubiquitination of the mRNA 3' end processing complex protein PCF11.
- Utilized cancer-specific MAGE-A11-HUWE1 ubiquitin ligase as a key factor.
- Screened for MAGE-A11 targets and analyzed the impact on mRNA processing complex components.
Main Results:
- Discovered that MAGE-A11 ubiquitinates PCF11, leading to the dissociation of CFIm25 from the processing complex.
- Demonstrated that this mechanism drives widespread APA and 3' US in cancer cells.
- Identified affected transcripts including oncogenes and tumor suppressors like cyclin D2 and PTEN.
Conclusions:
- MAGE-A11-mediated ubiquitination of PCF11 is a key driver of 3' US in cancer.
- This pathway contributes to altered expression of critical cancer-related genes.
- The findings suggest novel therapeutic strategies targeting MAGE-A11 or its associated pathway.
Related Concept Videos
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Nuclear Export of mRNA
Nuclear Export of mRNA

